Verve Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Verve Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2024.
Verve Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 1.59K %, a 5.55% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	1.59K	+83.7	+5.55%	Sep 30, 2024
Q2 2024	1.64K	+20	+1.24%	Jun 30, 2024
Q1 2024	1.64K	+68.9	+4.38%	Mar 31, 2024
Q4 2023	1.54K	-133	-7.96%	Dec 31, 2023
Q3 2023	1.51K	-191	-11.3%	Sep 30, 2023
Q2 2023	1.62K	-56.3	-3.36%	Jun 30, 2023
Q1 2023	1.57K	-726	-31.6%	Mar 31, 2023
Q4 2022	1.67K			Dec 31, 2022
Q3 2022	1.7K			Sep 30, 2022
Q2 2022	1.68K			Jun 30, 2022
Q1 2022	2.3K			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.